Republican opposition to Trump marijuana rescheduling could thwart other reforms
President Donald Trump broke with generations of tradition with his executive order last month to reclassify cannabis as a less dangerous drug under federal law. But as Politico and recent polling pointed out, Trump also defied voters and lawmakers within the MAGA...
Vireo Growth acquires former ‘Uber of Weed’ as cannabis M&A activity heats up
Cannabis multistate operator Vireo Growth last month agreed to acquire retailer and delivery platform Eaze, the onetime “Uber of weed,” in a $47 million all-stock deal. While the comparatively low acquisition price surprised some investors, others saw it...
Major cannabis edibles M&A as Wyld acquires competitor Grön
In a potential sign of future cannabis industry mergers and acquisition activity, two powerhouse names in edibles are merging. Portland-based Wyld is acquiring fellow Oregon favorite Grön in a deal expected to close early this year pending regulatory approval,...
New York cannabis sales hit $1.5 billion in 2025
New York’s legal cannabis market saw explosive growth in 2025, with sales topping $1.5 billion and the number of licensed marijuana shops more than doubling. By the end of 2025, there were 556 licensed retailers in New York – up from 261 in 2024, according to...
Chanda Macias’ mission is to make cannabis accessible worldwide
Chanda Macias is on a mission to bring medical cannabis to the world one country at a time. With over 25 years of experience in healthcare, education and business, the CEO of National Holistic Healing Center, a licensed medical cannabis dispensary in Washington, D.C.,...
Is 280E tax relief immediate? Your top marijuana rescheduling questions answered
President Donald Trump’s Dec. 18 executive order directing the Justice Department to officially classify cannabis as a less-dangerous drug with medicinal value under federal law is historic and transformative. But marijuana rescheduling is also generating confusion,...
Three trends affecting the U.S. cannabis industry in 2026
As the U.S. cannabis industry enters 2026, shifting market dynamics are reshaping how businesses operate and compete. From licensing activity to pricing behavior, patterns that emerged in 2025 offer a clearer picture of where the regulated market is stabilizing...
Can the cannabis industry send one of its own to Congress?
Wanda James is singing a familiar tune, one fans of reggae superstar Peter Tosh know well: “Legalize it.” But will that be enough for the $32 billion U.S. cannabis industry to be like other business sectors and send one of its own to Washington? ADVERTISEMENT James, a...
Great leaps in cannabis research expected after marijuana rescheduling
Kim Rivers runs a company that deals primarily in medical cannabis. Following President Donald Trump’s Dec. 18 move to relax federal restrictions on the drug, Rivers’ Florida-headquartered Trulieve Cannabis Corp. wants to bring a marijuana-based medicine to...
What cannabis investors should watch for in 2026 after marijuana rescheduling
(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.) Cannabis investors are understandably optimistic heading into 2026 after President Donald Trump’s historic Dec. 18 executive order. Marijuana...
Familiar foe claims credit for campaigns to end adult-use marijuana sales in Maine, Massachusetts
Cannabis reform’s sworn enemy is claiming credit for the quests to end adult-use marijuana sales in Maine and Massachusetts, where in the latter state signature-gatherers are allegedly resorting to deceptive tactics. Smart Approaches to Marijuana, a Washington,...Featured
1
Latest Sponsored
